TissUse establishes a liver-endocrine tissues multi-organ model for risk assessment with Bayer
Berlin, September 2018. TissUse has signed a collaboration agreement with Bayer to develop a highly innovative liver-endocrine tissues assay using TissUse’s Multi-Organ-Chip (MOC) technology.
Under the terms of the collaboration agreement, TissUse…